The antibiotic most commonly prescribed to treat bloodstream infections in dialysis patients may not always be the best choice, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). When Staphylococcus aureus bacteria gain access to a patient’s bloodstream, the infection then becomes life threatening. Antibiotics can often cure this infection, but without any antibiotic treatment, more than 80% of patients with bloodstream infections are likely to die. But what’s the most appropriate antibiotic to use?
